• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Spontaneous antithrombin in a patient with benign paraprotein.

作者信息

Gabriel D A, Carr M E, Cook L, Roberts H R

出版信息

Am J Hematol. 1987 May;25(1):85-93. doi: 10.1002/ajh.2830250109.

DOI:10.1002/ajh.2830250109
PMID:3578266
Abstract

A 66-year-old man with peptic ulcer disease developed a paraprotein that resulted in a spontaneously prolonged prothrombin time, activated partial thromboplastin time, and thrombin clotting time. Although the reptilase time was normal, the thrombin clotting time failed to correct with the addition of normal plasma, calcium, or protamine sulfate. The patient's purified fibrinogen was normal, but his serum contained an IgG that inhibited the clotting of normal plasma and purified fibrinogen in the presence of thrombin. In contrast to previously described paraproteins, this patient's IgG appeared to inhibit the activity of thrombin per se rather than to interfere with fibrinogen cleavage or fibrin polymerization. Although immunoprecipitation between thrombin and the paraprotein could not be demonstrated, the patient's purified IgG, in the presence of thrombin, decreased the thrombin activity on a chromogenic substrate. Further, increasing concentrations of thrombin overcame the inhibitory effect of the patient's paraprotein. Thus, the patient's paraprotein appeared to possess antithrombin activity.

摘要

相似文献

1
Spontaneous antithrombin in a patient with benign paraprotein.
Am J Hematol. 1987 May;25(1):85-93. doi: 10.1002/ajh.2830250109.
2
The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release.纤维蛋白肽B释放速率调节凝血形成速率:一项关于获得性纤维蛋白肽B释放抑制剂的研究。
Br J Haematol. 1991 Oct;79(2):296-301. doi: 10.1111/j.1365-2141.1991.tb04536.x.
3
A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer.一种凝血酶的糖胺聚糖抑制剂:癌症中异常止血检测的新机制。
Am J Hematol. 1991 Sep;38(1):24-9. doi: 10.1002/ajh.2830380105.
4
Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.一名复发性血栓形成患者的异常纤维蛋白原血症和狼疮抗凝物
J Lab Clin Med. 1987 Dec;110(6):726-33.
5
Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).纤维蛋白形成对血浆中凝血酶生成的抑制作用(抗凝血酶I)
Thromb Haemost. 2002 Aug;88(2):253-8.
6
Discovery and characterization of an antibody directed against exosite I of thrombin.发现并鉴定一种靶向凝血酶外切位点 I 的抗体。
J Thromb Haemost. 2016 Jan;14(1):137-42. doi: 10.1111/jth.13171. Epub 2015 Dec 29.
7
An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient.
Haematologica. 2007 Feb;92(2):e17-9. doi: 10.3324/haematol.10575.
8
Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder.
Br J Haematol. 1997 Apr;97(1):219-26. doi: 10.1046/j.1365-2141.1997.d01-2145.x.
9
Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.异常纤维蛋白原血症,其特征为纤维蛋白单体聚合异常而纤维蛋白肽A释放正常。
Br J Haematol. 1980 Mar;44(3):483-94. doi: 10.1111/j.1365-2141.1980.tb05918.x.
10
Inhibition of fibrin monomer polymerization by Bence Jones protein in a patient with primary amyloidosis.本-周蛋白对一名原发性淀粉样变性患者纤维蛋白单体聚合的抑制作用。
Acta Haematol. 1989;81(3):160-5. doi: 10.1159/000205551.

引用本文的文献

1
An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.一种针对该酶催化中心的获得性抗凝血酶自身抗体。
J Clin Invest. 1991 Jul;88(1):290-6. doi: 10.1172/JCI115290.